JNJ vs MRK

	JNJ Johnson & Johnson	MRK Merck & Co., Inc.
Price	$267.61	$147.24
Sector	Health Care	Health Care
X-Ray Score	49	33
Valuation	38	21
Growth	58	33
Profitability	57	44
Financial health	47	21
Dividends	42	56
Fair value	$244	$115
Verdict	Fair -9%	Overvalued -22%
Revenue (TTM)	$97.9B	$66.6B
Operating margin	26.8%	11.6%
Return on capital	19.3%	6.1%
Revenue growth (3y)	5.6%	3.1%
Free-cash-flow yield	3.4%	4.4%
Net debt / EBITDA	0.8×	6.1×
Dividend yield	2.0%	2.3%

Scores and fair values are model estimates from SEC filings, ranked within each company's own sector, so scores of companies in different sectors are not directly comparable. Educational only, not financial advice.